Cargando…
RNA m(6)A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
N(6)-Methyladenosine (m(6)A) RNA modification brings a new dawn for RNA modification researches in recent years. This posttranscriptional RNA modification is dynamic and reversible, and is regulated by methylases (“writers”), demethylases (“erasers”), and proteins that preferentially recognize m(6)A...
Autores principales: | Gu, Chang, Shi, Xin, Dai, Chenyang, Shen, Feng, Rocco, Gaetano, Chen, Jiafei, Huang, Zhengyu, Chen, Chunji, He, Chuan, Huang, Tao, Chen, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454620/ https://www.ncbi.nlm.nih.gov/pubmed/34557726 http://dx.doi.org/10.1016/j.xinn.2020.100066 |
Ejemplares similares
-
Hippo Pathway Core Genes Based Prognostic Signature and Immune Infiltration Patterns in Lung Squamous Cell Carcinoma
por: Gu, Chang, et al.
Publicado: (2021) -
Identification of Common Genes and Pathways in Eight Fibrosis Diseases
por: Gu, Chang, et al.
Publicado: (2021) -
Progress and application of epitranscriptomic m(6)A modification in gastric cancer
por: Xu, Yitian, et al.
Publicado: (2022) -
Roles and therapeutic implications of m6A modification in cancer immunotherapy
por: Pan, Juan, et al.
Publicado: (2023) -
The Role of m(6)A Modification and m(6)A Regulators in Esophageal Cancer
por: Li, Yuekao, et al.
Publicado: (2022)